Clinical Trial Update: Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 study evaluating plerixafor to rescue poor mobilizers in autologous stem cell transplantation has completed; results were posted in May 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Plerixafor (Plerixafor)

Snippet

Sponsor: Duke University | Conditions: Multiple Myeloma, Non-Hodgkins Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-05-07